Ameriprise
TCRT icon

Ameriprise’s Alaunos Therapeutics TCRT Stock Holding History

Ameriprise’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-910
Closed -$1.64M – 3936
2015
Q2 		$1.64M Buy
+910
New +$1.41M ﹤0.01% 2872
2014
Q4 		– Sell
-3
Closed -$1K – 4345
2014
Q3 		$1K Hold
3
– – ﹤0.01% 5579
2014
Q2 		$2K Sell
3
-5
-63% -$2.78K ﹤0.01% 5227
2014
Q1 		$5K Buy
8
+3
+60% +$2.01K ﹤0.01% 4788
2013
Q4 		$3K Sell
5
-28
-85% -$16.7K ﹤0.01% 4777
2013
Q3 		$20K Hold
33
– – ﹤0.01% 4421
2013
Q2 		$10K Buy
+33
New +$9.16K ﹤0.01% 4783

Other funds holding TCRT

UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise's TCRT Position: Q3 2015 in Review

Ameriprise sold out of Alaunos Therapeutics (TCRT) in Q3 2015, closing a stake of 910 shares — an estimated $1.64M sold.

Ameriprise first reported a position in TCRT in Q2 2013 and held it in 7 quarters. The position peaked at $1.64M in Q2 2015. 138 funds tracked by Wall St. Rank hold TCRT as of Q3 2015.

  • Ameriprise reported no remaining Alaunos Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Ameriprise sold 910 Alaunos Therapeutics shares in Q3 2015, an estimated $1.64M.
  • Ameriprise first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 7 quarters.
  • Ameriprise's Alaunos Therapeutics position peaked at $1.64M in Q2 2015.
  • 138 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2015.

Based on Ameriprise's 13F filing for Q3 2015, filed 12 Nov 2015.